Search Results - "Waqar Khalid Saeed"
-
1
The Use of Foxa2-Overexpressing Adipose Tissue-Derived Stem Cells in a Scaffold System Attenuates Acute Liver Injury
Published in Gut and liver (30-07-2019)“…Background/Aims: For the clinical application of stem cell therapy, functional enhancement is needed to increase the survival rate and the engraftment rate…”
Get full text
Journal Article -
2
The Use of Foxa2-Overexpressing Adipose Tissue-Derived Stem Cells in a Scaffold System Attenuates Acute Liver Injury
Published in Gut and liver (30-07-2019)“…Background/Aims: For the clinical application of stem cell therapy, functional enhancement is needed to increase the survival rate and the engraftment rate…”
Get full text
Journal Article -
3
The Use of Foxa2-Overexpressing Adipose Tissue-Derived Stem Cells in a Scaffold System Attenuates Acute Liver Injury
Published in Gut and liver (30-07-2019)“…Background/Aims: For the clinical application of stem cell therapy, functional enhancement is needed to increase the survival rate and the engraftment rate…”
Get full text
Journal Article -
4
The Use of Foxa2-Overexpressing Adipose Tissue-Derived Stem Cells in a Scaffold System Attenuates Acute Liver Injury
Published in Gut and liver (30-07-2019)“…Background/Aims: For the clinical application of stem cell therapy, functional enhancement is needed to increase the survival rate and the engraftment rate…”
Get full text
Journal Article -
5
Hepatic stellate cells activate and avoid death under necroptosis stimuli: Hepatic fibrosis during necroptosis
Published in Journal of gastroenterology and hepatology (01-12-2023)“…Necroptosis is an emerging cell death pathway that allows cells to undergo "cellular suicide" in a caspase-independent manner. We investigated the fate of…”
Get full text
Journal Article -
6
Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
Published in The Korean journal of internal medicine (31-03-2019)“…Background/Aims: A number of clinical trials reported varying effects of cho-lesterol lowering agents in nonalcoholic fatty liver disease (NAFLD) patients. We,…”
Get full text
Journal Article -
7
Necroptosis:An emerging type of cell death in liver diseases
Published in World journal of gastroenterology : WJG (21-09-2014)“…Cell death has been extensively evaluated for decades and it is well recognized that pharmacological interventions directed to inhibit cell death can prevent…”
Get full text
Journal Article -
8
The global emergence of Chikungunya infection: An integrated view
Published in Reviews in medical virology (01-05-2022)“…Summary Chikungunya virus (CHIKV) is one of the emerging viruses around the globe. It belongs to the family Togaviridae and genus Alphavirus and is an…”
Get full text
Journal Article -
9
Macro‐encapsulation of mesenchymal stem cells in acute and chronic liver injury animal models
Published in Journal of gastroenterology and hepatology (01-07-2021)“…Background and Aim Stem cell treatments using scaffolds for liver disease have been well studied. However, macro‐encapsulation of mesenchymal stem cells (MSCs)…”
Get full text
Journal Article -
10
Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver Disease
Published in Nutrients (22-03-2024)“…Previous studies have suggested that platelets are associated with inflammation and steatosis and may play an important role in liver health. Therefore, we…”
Get full text
Journal Article -
11
Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model
Published in Journal of gastroenterology and hepatology (01-12-2013)“…Background and Aim Several epidemiological studies have shown that coffee intake attenuates the progression of liver fibrosis; however, the mechanism is…”
Get full text
Journal Article -
12
Effect of Stem Cell Treatment on Acute Liver Failure Model Using Scaffold
Published in Digestive diseases and sciences (01-03-2019)“…Background Injecting MSCs via blood vessel is most commonly used method, which has a major drawback of safety. The aim of our study was to evaluate efficacy…”
Get full text
Journal Article -
13
Histologic and Metabolic Derangement in High-Fat, High-Fructose, and Combination Diet Animal Models
Published in TheScientificWorld (2015)“…Background. We used high-fat (HF), high-fructose (HFr), and combination diets to create a dietary animal model of nonalcoholic fatty liver disease (NAFLD)…”
Get full text
Journal Article -
14
Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
Published in The Korean journal of internal medicine (01-03-2019)“…A number of clinical trials reported varying effects of cholesterol lowering agents in nonalcoholic fatty liver disease (NAFLD) patients. We, therefore,…”
Get full text
Journal Article -
15
Feasibility and Stability of Liver Biopsy before Treatment for Preclinical Nonalcoholic Fatty Liver Studies
Published in Journal of Korean medical science (14-01-2019)“…The heterogeneity of histological findings in preclinical diet-induced nonalcoholic fatty liver disease (NAFLD) animal models is highly challenging. Here, we…”
Get full text
Journal Article -
16
The Use of Foxa2-Overexpressing Adipose Tissue-Derived Stem Cells in a Scaffold System Attenuates Acute Liver Injury
Published in Gut and liver (15-03-2019)“…For the clinical application of stem cell therapy, functional enhancement is needed to increase the survival rate and the engraftment rate. The purpose of this…”
Get full text
Journal Article -
17
Osthol attenuates hepatic steatosis via decreased triglyceride synthesis not by insulin resistance
Published in World journal of gastroenterology : WJG (07-09-2014)“…AIM: To evaluate the effects of osthol on intrahepatic fat synthesis, β-oxidation, inflammation, and insulin resistance by multifaceted analysis.METHODS:…”
Get full text
Journal Article -
18
Necroptosis signaling in liver diseases: An update
Published in Pharmacological research (01-10-2019)“…[Display omitted] •Role of RIPK3 and MLKL in NAFLD was diverse according to disease model and condition.•RIPK3 ablation seems to convincingly protect from…”
Get full text
Journal Article -
19
Decrease in fat de novo synthesis and chemokine ligand expression in non‐alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain‐like pseudokinase
Published in Journal of gastroenterology and hepatology (01-12-2019)“…Background and Aim Receptor‐interacting serine/threonine kinase 3 and mixed lineage kinase domain‐like pseudokinase (MLKL) have gained attention as apoptosis…”
Get full text
Journal Article -
20
Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis
Published in Digestive diseases and sciences (01-05-2024)“…Background and Aim he mixed lineage kinase domain like pseudokinase (MLKL) is known to play a protective role in non-alcoholic fatty liver disease (NAFLD) via…”
Get full text
Journal Article